Ha kapcsolatba szeretne lépni a Tudóstér adminisztrátoraival, kérjük töltse ki az alábbi űrlapot, vagy küldjön e-mailt a publikacioklib.unideb.hu címre.
Bejelentkezés
A Tudóstér funkcióinak nagy része bejelentkezés nélkül is elérhető. Bejelentkezésre az alábbi műveletekhez van szükség:
Rácz, L.,
Csépány, T.:
A parázsló betegség jelentősége a sclerosis multiplex progressziójában, a progresszió ellenőrzése képalkotó eljárás segítségével.
Ideggyogy. Szle. 78 (3-4), 79-85, 2025.
Roberts, J. I.,
Sharmin, S.,
Horakova, D.,
Kubala Havrdova, E.,
Ozakbas, S.,
Lugaresi, A.,
Tomassini, V.,
Alroughani, R.,
Buzzard, K.,
Skibina, O.,
Boz, C.,
Turkoglu, R.,
Maimone, D.,
Yamout, B.,
Khoury, S. J.,
Spitaleri, D.,
Lechner-Scott, J.,
Girard, M.,
Duquette, P.,
Al-Asmi, A.,
Ampapa, R.,
Foschi, M.,
Surcinelli, A.,
Patti, F.,
Pesch, V. v.,
Ramo-Tello, C.,
Sanchez-Menoyo, J.,
Altintas, A.,
Grammond, P.,
Cartechini, E.,
Csépány, T.,
Laureys, G.,
Willekens, B.,
Roos, I.,
Kalincik, T.,
MSBase Study Group:
Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years.
J. Neurol. Neurosurg. Psychiatry. [Epub ahead of print], 2025.
D'hondt, R.,
Dedja, K.,
Aerts, S.,
Wijmeersch, B. V.,
Kalincik, T.,
Reddel, S.,
Havrdova, E.,
Lugaresi, A.,
Weinstock-Guttman, B.,
Mrabet, S.,
Lalive, P. H.,
Kermode, A. G.,
Ozakbas, S.,
Patti, F.,
Prat, A.,
Tomassini, V.,
Roos, I.,
Alroughani, R.,
Gerlach, O.,
Khoury, S. J.,
Pesch, V. v.,
Sá, M. J.,
Prevost, J.,
Spitaleri, D.,
McCombe, P.,
Solaro, C.,
Walt, A. v. d.,
Butzkueven, H.,
Laureys, G.,
Sanchez-Menoyo, J.,
de Gans, K.,
Al-Asmi, A.,
Deri, N.,
Csépány, T.,
Al-Harbi, T.,
Carroll, W. M.,
Rózsa, C.,
Singhal, B.,
Hardy, T. A.,
Ramanathan, S.,
Peeters, L.,
Vens, C.,
MSBase Study Group:
Explainable time-to-progression predictions in multiple sclerosis.
Comput. Meth. Programs Biomed. 263, 1-23, (cikkazonosító: 108624), 2025.
Pirmani, A.,
De Brouwer, E.,
Arany, Á.,
Oldenhof, M.,
Passemiers, A.,
Faes, A.,
Kalincik, T.,
Ozakbas, S.,
Gouider, R.,
Willekens, B.,
Horakova, D.,
Havrdova, E.,
Patti, F.,
Prat, A.,
Lugaresi, A.,
Tomassini, V.,
Grammond, P.,
Cartechini, E.,
Roos, I.,
Boz, C.,
Alroughani, R.,
Amato, M. P.,
Buzzard, K.,
Lechner-Scott, J.,
Guimaraes, J.,
Solaro, C.,
Gerlach, O.,
Soysal, A.,
Kuhle, J.,
Sanchez-Menoyo, J.,
Spitaleri, D.,
Csépány, T.,
Wijmeersch, B. V.,
Ampapa, R.,
Prevost, J.,
Khoury, S. J.,
Pesch, V. v.,
John, N.,
Maimone, D.,
Weinstock-Guttman, B.,
Laureys, G.,
McCombe, P.,
Blanco, Y.,
Altintas, A.,
Al-Asmi, A.,
Garber, J.,
Walt, A. v. d.,
Butzkueven, H.,
de Gans, K.,
Rózsa, C.,
Taylor, B. V.,
Al-Harbi, T.,
Sas, A.,
Rajda, C.,
Gray, O.,
Decoo, D.,
Carroll, W. M.,
Kermode, A. G.,
Fabis-Pedrini, M.,
Mason, D.,
Perez-Sempere, A.,
Simu, M.,
Shuey, N.,
Singhal, B.,
Cauchi, M.,
Hardy, T. A.,
Ramanathan, S.,
Lalive, P. H.,
Sirbu, C. A.,
Hughes, S.,
Castillo Triviño, T.,
Peeters, L.,
Moreau, Y.:
Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data.
npj Digit. Med. 8 (1), 1-15, (cikkazonosító: 478), 2025.
Siriratnam, P.,
Sanfilippo, P.,
Walt, A. v. d.,
Sharmin, S.,
Foong, Y. C.,
Yeh, W. Z.,
Zhu, C.,
Khoury, S. J.,
Csépány, T.,
Willekens, B.,
Etemadifar, M.,
Ozakbas, S.,
Nytrova, P.,
Altintas, A.,
Al-Asmi, A.,
Yamout, B.,
Laureys, G.,
Patti, F.,
Simó, M.,
Surcinelli, A.,
Foschi, M.,
McCombe, P.,
Alroughani, R.,
Sanchez-Menoyo, J.,
Turkoglu, R.,
Soysal, A.,
Lechner Scott, J.,
Kalincik, T.,
Butzkueven, H.,
Jokubaitis, V.,
Huda, S.,
Monif, M.,
MSBase Study Group:
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: a multicentre study.
J. Neurol. Neurosurg. Psychiatry. 96 (4), 361-369, (cikkazonosító: 2024), 2025.
Shipley, J.,
Beadnall, H. N.,
Sanfilippo, P.,
Yeh, W. Z.,
Horakova, D.,
Havrdova, E.,
Hradilek, P.,
Kalincik, T.,
Roos, I.,
Prat, A.,
Girard, M.,
Rous, Z.,
Pavelek, Z.,
Gerlach, O.,
Lechner-Scott, J.,
Alroughani, R.,
Ozakbas, S.,
Peterka, M.,
Buzzard, K.,
Skibina, O.,
Maimone, D.,
Foschi, M.,
Surcinelli, A.,
Karabudak, R.,
Spitaleri, D. L. A.,
Lugaresi, A.,
Tomassini, V.,
Gouider, R.,
Mrabet, S.,
Ferrando, B. R.,
Hodgkinson, S.,
Stourac, P.,
Guimaraes, J.,
John, N.,
Macdonell, R.,
Meca-Lallana, J. E.,
Butzkueven, H.,
Walt, A. v. d.,
Jokubaitis, V.,
MSBase Study Group:
Pregnancy-Related Disease Outcomes in Women With Moderate to Severe Multiple Sclerosis Disability.
JAMA Netw Open. 8 (9), 1-14, (cikkazonosító: 2531581), 2025.
Cortese, M.,
Peng, X.,
Edan, G.,
Freedman, M. S.,
Hartung, H. P.,
Montalbán, X.,
Sandbrink, R.,
Radü, E. W.,
Barkhof, F.,
Wicklein, E. M.,
Kappos, L.,
Ascherio, A.,
Bjornevik, K.,
BENEFIT Study Group:
Serum Alpha-Linolenic Acid and Long-Term Multiple Sclerosis Activity and Progression.
Neurology. 105 (3), 1-11, (cikkazonosító: 213905), 2025.
Csépány, T.,
Rózsa, C.,
Deme, I.,
Mike, A.,
Bencsik, K.,
Bereczki, D.,
Bíró, Z.,
Illés, Z.,
Jakab, G.,
Jobbágy, Z.,
Komoly, S.,
Lovas, G.,
Mátyás, K.,
Rajda, C.,
Simó, M.,
Vécsei, L.:
A Magyar Neuroimmunológiai Társaság szakmai ajánlása: A sclerosis multiplex diagnosztikájáról és kezeléséről.
Ideggyógy. Szle. Proc. 9 (1), 1-59, 2024.
Spelman, T.,
Herring, W. L.,
Acosta, C.,
Hyde, R.,
Jokubaitis, V.,
Pucci, E.,
Lugaresi, A.,
Laureys, G.,
Havrdova, E.,
Horakova, D.,
Izquierdo, G.,
Eichau, S.,
Ozakbas, S.,
Alroughani, R.,
Kalincik, T.,
Duquette, P.,
Girard, M.,
Petersen, T.,
Patti, F.,
Csépány, T.,
Granella, F.,
Grand'Maison, F.,
Ferraro, D.,
Karabudak, R.,
José Sá, M.,
Trojano, M.,
Pesch, V. v.,
Wijmeersch, B. V.,
Cartechini, E.,
McCombe, P.,
Gerlach, O.,
Spitaleri, D.,
Rózsa, C.,
Hodgkinson, S.,
Bergamaschi, R.,
Gouider, R.,
Soysal, A.,
Prevost, J.,
Garber, J.,
de Gans, K.,
Ampapa, R.,
Simó, M.,
Sanchez-Menoyo, J.,
Iuliano, G.,
Sas, A.,
Walt, A. v. d.,
John, N.,
Gray, O.,
Hughes, S.,
De Luca, G.,
Onofrj, M.,
Buzzard, K.,
Skibina, O.,
Terzi, M.,
Slee, M.,
Solaro, C.,
Ramo-Tello, C.,
Fragoso, Y.,
Shaygannejad, V.,
Moore, F.,
Rajda, C.,
Aguera-Morales, E.,
Butzkueven, H.:
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.
J Med Econ. 27 (1), 109-125, 2024.
Li, Y.,
Saul, A.,
Taylor, B. V.,
Ponsonby, A. L.,
Simpson-Yap, S.,
Blizzard, L.,
Broadley, S.,
Lechner-Scott, J.,
Karabudak, R.,
Patti, F.,
Eichau, S.,
Onofrj, M.,
Ozakbas, S.,
Horakova, D.,
Kubala Havrdova, E.,
Grand'Maison, F.,
Alroughani, R.,
Gerlach, O.,
Amato, M. P.,
Altintas, A.,
Girard, M.,
Duquette, P.,
Blanco, Y.,
Ramo-Tello, C.,
Laureys, G.,
Kalincik, T.,
Khoury, S. J.,
Shaygannejad, V.,
Etemadifar, M.,
Singhal, B.,
Mrabet, S.,
Foschi, M.,
Habek, M.,
John, N.,
Hughes, S.,
McCombe, P.,
Ampapa, R.,
Walt, A. v. d.,
Butzkueven, H.,
de Gans, K.,
McGuigan, C.,
Oreja-Guevara, C.,
Sá, M. J.,
Petersen, T.,
Al-Harbi, T.,
Sempere, P. A.,
Wijmeersch, B. V.,
Grigoriadis, N.,
Prevost, J.,
Gray, O.,
Castillo Triviño, T.,
Macdonell, R.,
Lugaresi, A.,
Sajedi, S. A.,
Mei, I. v. d.,
Ausimmune/AusLong Investigators Group,
MSBase Study Group:
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies.
J. Neurol. 271 (1), 472-485, 2024.
De Brouwer, E.,
Becker, T.,
Werthen-Brabants, L.,
Dewulf, P.,
Iliadis, D.,
Dekeyser, C.,
Laureys, G.,
Wijmeersch, B. V.,
Popescu, V.,
Dhaene, T.,
Deschrijver, D.,
Waegeman, W.,
De Baets, B.,
Stock, M. J.,
Horakova, D.,
Patti, F.,
Izquierdo, G.,
Eichau, S.,
Girard, M.,
Prat, A.,
Lugaresi, A.,
Grammond, P.,
Kalincik, T.,
Alroughani, R.,
Grand'Maison, F.,
Skibina, O.,
Terzi, M.,
Lechner-Scott, J.,
Gerlach, O.,
Khoury, S. J.,
Cartechini, E.,
Pesch, V. v.,
Sá, M. J.,
Weinstock-Guttman, B.,
Blanco, Y.,
Ampapa, R.,
Spitaleri, D.,
Solaro, C.,
Maimone, D.,
Soysal, A.,
Iuliano, G.,
Gouider, R.,
Castillo Triviño, T.,
Sanchez-Menoyo, J.,
Laureys, G.,
Walt, A. v. d.,
Oh, J.,
Aguera-Morales, E.,
Altintas, A.,
Al-Asmi, A.,
de Gans, K.,
Fragoso, Y.,
Csépány, T.,
Hodgkinson, S.,
Deri, N.,
Al-Harbi, T.,
Taylor, B. V.,
Gray, O.,
Lalive, P. H.,
Rózsa, C.,
McGuigan, C.,
Kermode, A. G.,
Sempere, P. A.,
Mihaela, S.,
Simó, M.,
Hardy, T. A.,
Decoo, D.,
Hughes, S.,
Grigoriadis, N.,
Sas, A.,
Vella, N.,
Moreau, Y.,
Peeters, L.:
Machine-learning-based prediction of disability progression in multiple sclerosis: an observational, international, multi-center study.
PLOS Digit. Health. 3 (7), 1-25, (cikkazonosító: 0000533), 2024.
Siriratnam, P.,
Huda, S.,
Walt, A. v. d.,
Sanfilippo, P.,
Sharmin, S.,
Foong, Y. C.,
Yeh, W. Z.,
Zhu, C.,
Khoury, S. J.,
Csépány, T.,
Willekens, B.,
Etemadifar, M.,
Ozakbas, S.,
Nytrova, P.,
Altintas, A.,
Al-Asmi, A.,
Ramo-Tello, C.,
Laureys, G.,
Patti, F.,
Horakova, D.,
Foschi, M.,
Boz, C.,
McCombe, P.,
Turkoglu, R.,
Lechner-Scott, J.,
Roos, I.,
Kalincik, T.,
Jokubaitis, V.,
Butzkueven, H.,
Monif, M.,
MSBase Study Group:
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD.
Neurology. 103 (12), 1-8, (cikkazonosító: 209940), 2024.
Dekeyser, C.,
Hautekeete, M.,
Cambron, M.,
Pesch, V. v.,
Patti, F.,
Kuhle, J.,
Khoury, S. J.,
Lechner Scott, J.,
Gerlach, O.,
Lugaresi, A.,
Maimone, D.,
Surcinelli, A.,
Grammond, P.,
Kalincik, T.,
Habek, M.,
Willekens, B.,
Macdonell, R.,
Lalive, P. H.,
Csépány, T.,
Butzkueven, H.,
Boz, C.,
Tomassini, V.,
Foschi, M.,
Sanchez-Menoyo, J.,
Altintas, A.,
Mrabet, S.,
Iuliano, G.,
Sá, M. J.,
Alroughani, R.,
Karabudak, R.,
Aguera-Morales, E.,
Gray, O.,
de Gans, K.,
Walt, A. v. d.,
McCombe, P.,
Deri, N.,
Garber, J.,
Al-Asmi, A.,
Skibina, O.,
Duquette, P.,
Cartechini, E.,
Spitaleri, D.,
Gouider, R.,
Soysal, A.,
Van Hijfte, L.,
Slee, M.,
Amato, M. P.,
Buzzard, K.,
Laureys, G.:
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
J. Neurol. Neurosurg. Psychiatry. 95 (11), 1021-1031, 2024.
Roos, I.,
Diouf, I.,
Sharmin, S.,
Horakova, D.,
Havrdova, E.,
Patti, F.,
Shaygannejad, V.,
Ozakbas, S.,
Izquierdo, G.,
Eichau, S.,
Onofrj, M.,
Lugaresi, A.,
Alroughani, R.,
Prat, A.,
Girard, M.,
Duquette, P.,
Terzi, M.,
Boz, C.,
Grand'Maison, F.,
Sola, P.,
Ferraro, D.,
Grammond, P.,
Turkoglu, R.,
Buzzard, K.,
Skibina, O.,
Yamout, B.,
Altintas, A.,
Gerlach, O.,
Pesch, V. v.,
Blanco, Y.,
Maimone, D.,
Lechner-Scott, J.,
Bergamaschi, R.,
Karabudak, R.,
McGuigan, C.,
Cartechini, E.,
Barnett, M.,
Hughes, S.,
Sá, M. J.,
Solaro, C.,
Ramo-Tello, C.,
Hodgkinson, S.,
Spitaleri, D.,
Soysal, A.,
Petersen, T.,
Granella, F.,
de Gans, K.,
McCombe, P.,
Ampapa, R.,
Wijmeersch, B. V.,
Walt, A. v. d.,
Butzkueven, H.,
Prevost, J.,
Sanchez-Menoyo, J.,
Laureys, G.,
Gouider, R.,
Castillo Triviño, T.,
Gray, O.,
Aguera-Morales, E.,
Al-Asmi, A.,
Shaw, C.,
Deri, N.,
Al-Harbi, T.,
Fragoso, Y.,
Csépány, T.,
Sempere, P. A.,
Trevino-Frenk, I.,
Schepel, J.,
Moore, F.,
Malpas, C.,
Kalincik, T.,
MSBase Study Group:
Comparative effectiveness in multiple sclerosis: A methodological comparison.
Mult. Scler. 29 (3), 326-332, 2023.
Kalincik, T.,
Sharmin, S.,
Roos, I.,
Freedman, M. S.,
Atkins, H.,
Burman, J.,
Massey, J.,
Sutton, I.,
Withers, B.,
Macdonell, R.,
Grigg, A.,
Torkildsen, ø.,
Bo, L.,
Lehmann, A. K.,
Kubala Havrdova, E.,
Krasulova, E.,
Trneny, M.,
Kozak, T.,
Walt, A. v. d.,
Butzkueven, H.,
McCombe, P.,
Skibina, O.,
Lechner-Scott, J.,
Willekens, B.,
Cartechini, E.,
Ozakbas, S.,
Alroughani, R.,
Kuhle, J.,
Patti, F.,
Duquette, P.,
Lugaresi, A.,
Khoury, S. J.,
Slee, M.,
Turkoglu, R.,
Hodgkinson, S.,
John, N.,
Maimone, D.,
José Sá, M.,
Pesch, V. v.,
Gerlach, O.,
Laureys, G.,
Van Hijfte, L.,
Karabudak, R.,
Spitaleri, D.,
Csépány, T.,
Gouider, R.,
Castillo Triviño, T.,
Taylor, B. V.,
Sharrack, B.,
Snowden, J. A.,
MSBase Study Group:
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
JAMA Neurol. 80 (7), 702-713, 2023.
Diouf, I.,
Malpas, C. B.,
Sharmin, S.,
Roos, I.,
Horakova, D.,
Kubala Havrdova, E.,
Patti, F.,
Shaygannejad, V.,
Ozakbas, S.,
Eichau, S.,
Onofrj, M.,
Lugaresi, A.,
Alroughani, R.,
Prat, A.,
Duquette, P.,
Terzi, M.,
Boz, C.,
Grand'Maison, F.,
Sola, P.,
Ferraro, D.,
Grammond, P.,
Yamout, B.,
Altintas, A.,
Gerlach, O.,
Lechner-Scott, J.,
Bergamaschi, R.,
Karabudak, R.,
Iuliano, G.,
McGuigan, C.,
Cartechini, E.,
Hughes, S.,
Sá, M. J.,
Solaro, C.,
Kappos, L.,
Hodgkinson, S.,
Slee, M.,
Granella, F.,
de Gans, K.,
McCombe, P.,
Ampapa, R.,
Walt, A. v. d.,
Butzkueven, H.,
Sanchez-Menoyo, J.,
Vucic, S.,
Laureys, G.,
Sidhom, Y.,
Gouider, R.,
Castillo Triviño, T.,
Gray, O.,
Aguera-Morales, E.,
Al-Asmi, A.,
Shaw, C.,
Al-Harbi, T.,
Csépány, T.,
Sempere, P. A.,
Trevino-Frenk, I.,
Stuart, E. A.,
Kalincik, T.:
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.
J. Neurol. Neurosurg. Psychiatry. 94 (12), 1004-1011, 2023.
Spelman, T.,
Horakova, D.,
Ozakbas, S.,
Alroughani, R.,
Onofrj, M.,
Kalincik, T.,
Prat, A.,
Terzi, M.,
Grammond, P.,
Patti, F.,
Csépány, T.,
Boz, C.,
Lechner-Scott, J.,
Granella, F.,
Grand'Maison, F.,
Walt, A. v. d.,
Zhu, C.,
Butzkueven, H.,
MSBase Study Group:
Switching to natalizumab or fingolimod in multiple sclerosis: comparative effectiveness and effect of pre-switch disease activity.
Mult. Scler. Relat. Disord. 70, 1-8, (cikkazonosító: 104477), 2023.
Sharmin, S.,
Roos, I.,
Simpson-Yap, S.,
Malpas, C.,
Sánchez, M. M.,
Ozakbas, S.,
Horakova, D.,
Havrdova, E.,
Patti, F.,
Alroughani, R.,
Izquierdo, G.,
Eichau, S.,
Boz, C.,
Zakaria, M.,
Onofrj, M.,
Lugaresi, A.,
Weinstock-Guttman, B.,
Prat, A.,
Girard, M.,
Duquette, P.,
Terzi, M.,
Amato, M. P.,
Karabudak, R.,
Grand'Maison, F.,
Khoury, S. J.,
Grammond, P.,
Lechner-Scott, J.,
Buzzard, K.,
Skibina, O.,
Walt, A. v. d.,
Butzkueven, H.,
Turkoglu, R.,
Altintas, A.,
Maimone, D.,
Kermode, A. G.,
Shalaby, N.,
Pesch, V. v.,
Butler, E.,
Sidhom, Y.,
Gouider, R.,
Mrabet, S.,
Gerlach, O.,
Soysal, A.,
Barnett, M.,
Kuhle, J.,
Hughes, S.,
Sá, M. J.,
Hodgkinson, S.,
Oreja-Guevara, C.,
Ampapa, R.,
Petersen, T.,
Ramo-Tello, C.,
Spitaleri, D.,
McCombe, P.,
Taylor, B. V.,
Prevost, J.,
Foschi, M.,
Slee, M.,
McGuigan, C.,
Laureys, G.,
Hijfte, L. V.,
de Gans, K.,
Solaro, C.,
Oh, J.,
Macdonell, R.,
Aguera-Morales, E.,
Singhal, B.,
Gray, O.,
Garber, J.,
Wijmeersch, B. V.,
Mihaela, S.,
Castillo Triviño, T.,
Sanchez-Menoyo, J.,
Khurana, D.,
Al-Asmi, A.,
Al-Harbi, T.,
Deri, N.,
Fragoso, Y.,
Lalive, P. H.,
Sinnige, L. G. F.,
Shaw, C.,
Shuey, N.,
Csépány, T.,
Sempere, P. A.,
Moore, F.,
Decoo, D.,
Willekens, B.,
Gobbi, C.,
Massey, J.,
Hardy, T. A.,
Parratt, J.,
Kalincik, T.,
the MSBase investigators:
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Brain. 146 (11), 4633-4644, 2023.
Diouf, I.,
Malpas, C. B.,
Sharmin, S.,
Roos, I.,
Horakova, D.,
Havrdova, E.,
Patti, F.,
Shaygannejad, V.,
Ozakbas, S.,
Izquierdo, G.,
Eichau, S.,
Onofrj, M.,
Lugaresi, A.,
Alroughani, R.,
Prat, A.,
Girard, M.,
Duquette, P.,
Terzi, M.,
Boz, C.,
Grand'Maison, F.,
Hamdy, S.,
Sola, P.,
Ferraro, D.,
Grammond, P.,
Turkoglu, R.,
Buzzard, K.,
Skibina, O.,
Yamout, B.,
Altintas, A.,
Gerlach, O.,
Pesch, V. v.,
Blanco, Y.,
Maimone, D.,
Lechner-Scott, J.,
Bergamaschi, R.,
Karabudak, R.,
Iuliano, G.,
McGuigan, C.,
Cartechini, E.,
Barnett, M.,
Hughes, S.,
Sá, M. J.,
Solaro, C.,
Kappos, L.,
Ramo-Tello, C.,
Cristiano, E.,
Hodgkinson, S.,
Spitaleri, D.,
Soysal, A.,
Petersen, T.,
Slee, M.,
Butler, E.,
Granella, F.,
de Gans, K.,
McCombe, P.,
Ampapa, R.,
Wijmeersch, B. V.,
Walt, A. v. d.,
Butzkueven, H.,
Prevost, J.,
Sinnige, L. G. F.,
Sanchez-Menoyo, J.,
Vucic, S.,
Laureys, G.,
Van Hijfte, L.,
Khurana, D.,
Macdonell, R.,
Gouider, R.,
Castillo Triviño, T.,
Gray, O.,
Aguera-Morales, E.,
Al-Asmi, A.,
Shaw, C.,
Deri, N.,
Al-Harbi, T.,
Fragoso, Y.,
Csépány, T.,
Perez Sempere, A.,
Trevino-Frenk, I.,
Schepel, J.,
Moore, F.,
Kalincik, T.:
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Eur. J. Neurol. 30 (4), 1014-1024, (cikkazonosító: 15706), 2023.
Sharmin, S.,
Bovis, F.,
Malpas, C.,
Horakova, D.,
Havrdova, E.,
Izquierdo, G.,
Eichau, S.,
Trojano, M.,
Prat, A.,
Girard, M.,
Duquette, P.,
Onofrj, M.,
Lugaresi, A.,
Grand'Maison, F.,
Grammond, P.,
Sola, P.,
Ferraro, D.,
Terzi, M.,
Gerlach, O.,
Alroughani, R.,
Boz, C.,
Shaygannejad, V.,
Pesch, V. v.,
Cartechini, E.,
Kappos, L.,
Lechner-Scott, J.,
Bergamaschi, R.,
Turkoglu, R.,
Solaro, C.,
Iuliano, G.,
Granella, F.,
Wijmeersch, B. V.,
Spitaleri, D.,
Slee, M.,
McCombe, P.,
Prevost, J.,
Ampapa, R.,
Ozakbas, S.,
Sanchez-Menoyo, J.,
Soysal, A.,
Vucic, S.,
Petersen, T.,
de Gans, K.,
Butler, E.,
Hodgkinson, S.,
Sidhom, Y.,
Gouider, R.,
Cristiano, E.,
Castillo Triviño, T.,
Saladino, M. L.,
Barnett, M.,
Moore, F.,
Rózsa, C.,
Yamout, B.,
Skibina, O.,
Walt, A. v. d.,
Buzzard, K.,
Gray, O.,
Hughes, S.,
Sempere, P. A.,
Singhal, B.,
Fragoso, Y.,
Shaw, C.,
Kermode, A. G.,
Taylor, B. V.,
Simó, M.,
Shuey, N.,
Al-Harbi, T.,
Macdonell, R.,
Dominguez, J. A.,
Csépány, T.,
Sirbu, C. A.,
Sormani, M. P.,
Butzkueven, H.,
Kalincik, T.:
Confirmed disability progression as a marker of permanent disability in multiple sclerosis.
Eur. J. Neurol. 29 (8), 2321-2334, 2022.
